Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Egypt Natl Canc Inst ; 31(1): 10, 2019 Dec 30.
Artigo em Inglês | MEDLINE | ID: mdl-32372137

RESUMO

BACKGROUND: Plantago lanceolata L. is used in Iraqi folklore medicine to treat injuries, and its extract is prescribed by some herbalists for cancer patients. This research aimed to evaluate the effect of P. lanceolata leaf extract on breast cancer cell lines in vitro and to identify its active compounds. Crystal violet viability assay was used to determine the cytotoxicity of methanolic P. lanceolata leaf extract against various breast cancer cell lines. MCF7, AMJ13, MDAMB, and CAL51 human breast cancer cells were treated with different concentrations of the extract for 72 h. The morphology of the treated cells was examined under a phase-contrast inverted microscope. The clonogenic ability was assessed through a clonogenic assay. High-performance liquid chromatography (HPLC) analysis was performed to measure the concentrations of phenols and flavonoids in the extract. RESULTS: The methanolic P. lanceolata leaf extract significantly inhibited the proliferation of triple-negative CAL51 cells but showed minor effect on the other breast cancer cells. In addition, at high doses, it induced cytopathic morphological changes. The clonogenic assay showed low colony formation in the exposed cells, especially CAL51 cells. Furthermore, HPLC study revealed that the methanolic extract contained important flavonoid glycosides, especially rutin, myricetin quercetin, and kaempferol. CONCLUSIONS: P. lanceolata leaf extract selectively inhibited the proliferation of CAL51 triple-negative breast cancer cells and showed minor effect on the other breast cancer cells types studied. Thus, this study showed P. lanceolata as a possible natural source of selective anti-triple-negative breast cancer drugs.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Extratos Vegetais/farmacologia , Plantago/química , Antineoplásicos Fitogênicos/química , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/patologia , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Feminino , Flavonoides/análise , Humanos , Fenóis/análise , Extratos Vegetais/química , Folhas de Planta/química
2.
J Infect Dev Ctries ; 10(6): 619-25, 2016 Jun 30.
Artigo em Inglês | MEDLINE | ID: mdl-27367011

RESUMO

INTRODUCTION: Data on blood-borne viral infections in some regions in Saudi Arabia remain scarce. This study investigates the prevalence of serological markers and nucleic acid for blood-borne viruses among blood donors in Al-Baha, Kingdom of Saudi Arabia. METHODOLOGY: In this cross-sectional study, 2,807 donors who donated blood between January 2009 and November 2011 were investigated for blood-borne viral serological markers including HBsAg, anti-HBc, anti-HBs, anti-HCV, anti-HIV, and anti-HTLVI/III in addition to viral nucleic acid. RESULTS: All donors were males between 16 to 66 years of age (mean: 31.5 ± 9.3 years). Viral nucleic acid and/or serological markers were detected in a total of 36 (1.3%) donors; of them, 26 (72.2%) had nucleic acid concomitant with serological markers, 6 (16.7%) had only viral nucleic acid, while 4 (11.1%) had only serological markers. Of all donors, 22 (0.8%) had HBsAg, 227 (8.0%) had anti-HBc, 157 (5.0%) had anti-HBs, 2,577 (91.8%) had no HBV markers, 2 (0.07%) had anti-HIV, 1 (0.04%) had anti-HCV, and 1 (0.04%) had anti-HTLVI/II. The donors who were born during HBV vaccination era showed no HBsAg (0.0%; p = 0.052), lower rates of anti-HBc (1.5%; p < 0.001) and anti-HBs (0.7%; p < 0.001), while the majority had no HBV markers (98.5%; p < 0.001). CONCLUSIONS: Combined viral nucleic acid and serological testing of donated blood enhances blood safety. The absence of HBV markers among donors suggests susceptibility or declined anti-HBs levels. Thus, HBV revaccination or a vaccine boost among adolescents and adults might be indispensable.


Assuntos
Doadores de Sangue , Patógenos Transmitidos pelo Sangue/isolamento & purificação , Viroses/epidemiologia , Adolescente , Adulto , Idoso , Anticorpos Antivirais/sangue , Antígenos Virais/sangue , Estudos Transversais , DNA Viral/sangue , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , RNA Viral/sangue , Arábia Saudita/epidemiologia , Adulto Jovem
3.
Hepatogastroenterology ; 52(64): 1039-41, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16001625

RESUMO

A wide or enlarged cystic duct is a common encounter in laparoscopic cholecystectomy. Many techniques are used to secure its ligation; including internal or extracorporeal knots and Roeder knot. A preformed knot can be used e.g. ETHIBINDER; the Endoloop. The Endo GIA is a useful stapling device but is more expensive. Other simpler techniques have also been described. The author developed a new, simple, safe and quick technique to ligate the wide cystic duct utilizing the commonly used multiple clip appliers. The technique does not need special skill or instruments and ensures complete ligation of the wide cystic duct using overlapping of the clips.


Assuntos
Colecistectomia Laparoscópica/métodos , Colecistite/cirurgia , Ducto Cístico/cirurgia , Adulto , Colecistectomia Laparoscópica/instrumentação , Colecistite/etiologia , Colecistite/patologia , Ducto Cístico/patologia , Feminino , Cálculos Biliares/complicações , Humanos , Ligadura/instrumentação , Ligadura/métodos , Pessoa de Meia-Idade , Técnicas de Sutura/instrumentação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...